Vontobel Holding Ltd. Trims Stock Position in Cardinal Health, Inc. $CAH

Vontobel Holding Ltd. cut its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 39.4% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 39,471 shares of the company’s stock after selling 25,610 shares during the period. Vontobel Holding Ltd.’s holdings in Cardinal Health were worth $6,631,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in the stock. JPMorgan Chase & Co. increased its position in shares of Cardinal Health by 40.0% during the first quarter. JPMorgan Chase & Co. now owns 4,175,992 shares of the company’s stock valued at $575,327,000 after acquiring an additional 1,193,983 shares during the last quarter. Northern Trust Corp increased its position in shares of Cardinal Health by 3.5% during the first quarter. Northern Trust Corp now owns 3,143,003 shares of the company’s stock valued at $433,012,000 after acquiring an additional 105,154 shares during the last quarter. Wellington Management Group LLP increased its position in shares of Cardinal Health by 1,666.7% during the first quarter. Wellington Management Group LLP now owns 2,384,192 shares of the company’s stock valued at $328,470,000 after acquiring an additional 2,249,241 shares during the last quarter. Price T Rowe Associates Inc. MD increased its position in shares of Cardinal Health by 3.3% during the first quarter. Price T Rowe Associates Inc. MD now owns 1,654,036 shares of the company’s stock valued at $227,877,000 after acquiring an additional 52,714 shares during the last quarter. Finally, Dimensional Fund Advisors LP increased its position in shares of Cardinal Health by 0.6% during the first quarter. Dimensional Fund Advisors LP now owns 1,246,788 shares of the company’s stock valued at $171,749,000 after acquiring an additional 7,940 shares during the last quarter. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on the stock. Evercore ISI dropped their price target on shares of Cardinal Health from $200.00 to $190.00 and set an “outperform” rating for the company in a research report on Wednesday, August 13th. Citigroup reiterated a “neutral” rating and set a $170.00 price target (up from $157.00) on shares of Cardinal Health in a research report on Friday, June 13th. Jefferies Financial Group set a $150.00 price objective on shares of Cardinal Health in a report on Tuesday, August 12th. UBS Group restated a “buy” rating on shares of Cardinal Health in a report on Tuesday, August 12th. Finally, Weiss Ratings restated a “buy (b)” rating on shares of Cardinal Health in a report on Wednesday. Twelve research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $166.00.

Cardinal Health Stock Down 0.2%

Shares of Cardinal Health stock opened at $156.86 on Friday. Cardinal Health, Inc. has a 52-week low of $106.98 and a 52-week high of $168.44. The company has a 50 day moving average of $152.09 and a 200 day moving average of $151.09. The company has a market capitalization of $37.27 billion, a P/E ratio of 24.32, a P/E/G ratio of 1.33 and a beta of 0.71.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.03 by $0.05. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The company had revenue of $60.16 billion during the quarter, compared to the consensus estimate of $60.91 billion. During the same quarter in the previous year, the firm earned $1.84 earnings per share. The firm’s quarterly revenue was up .5% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. As a group, research analysts anticipate that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be paid a $0.5107 dividend. The ex-dividend date is Wednesday, October 1st. This represents a $2.04 dividend on an annualized basis and a yield of 1.3%. Cardinal Health’s payout ratio is currently 31.63%.

Insider Buying and Selling

In related news, CEO Jason M. Hollar sold 107,705 shares of Cardinal Health stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $148.90, for a total value of $16,037,274.50. Following the completion of the transaction, the chief executive officer owned 235,901 shares in the company, valued at $35,125,658.90. The trade was a 31.35% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Jessica L. Mayer sold 38,078 shares of Cardinal Health stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total transaction of $5,666,767.96. Following the completion of the transaction, the insider owned 48,457 shares of the company’s stock, valued at $7,211,370.74. This represents a 44.00% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 271,676 shares of company stock valued at $40,489,525 over the last ninety days. 0.12% of the stock is currently owned by corporate insiders.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.